Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'r pfi 2 hydrochloride'

Search results for: 'r pfi 2 hydrochloride'

Items 41-50 of 63

Page
per page
  1. Lapatinib Ditosylate
    A3967 Lapatinib Ditosylate
    Target: EGFR|ErbB-2
    Summary: EGFR/HER2 inhibitor,potent and selective
      ≥24.3 mg/mL
  2. Neratinib (HKI-272)
    A8322 Neratinib (HKI-272)
     1 Citation
    Target: EGFR
    Summary: HER2/EGFR inhibitor,potent and irreversible
      insoluble in H2O; ≥13.93 mg/mL
  3. TG 100801
    A3870 TG 100801
    Target: VEGFR|FGFR|Src|Fyn kinase
    Summary: Multi-kinase inhibitor
      Soluble in DMSO
  4. LY2801653
    A3573 LY2801653
    Target: MET
    Summary: MET inhibitor
      ≥27.65 mg/mL
  5. Nintedanib (BIBF 1120)
    A8252 Nintedanib (BIBF 1120)
     3 Citation
    Target: VEGFR|PDGFR|FGFR
    Summary: VEGFR/PDGFR/FGFR inhibitor
      insoluble in H2O; insoluble in EtOH; ≥5.34 mg/mL
  6. GS-9973
    B3553 GS-9973
    Target: Syk
    Summary: Syk inhibitor, orally bioavailable and selective
      insoluble in EtOH; insoluble in H2O; ≥20.55 mg/mL
  7. CZC-25146
    B4635 CZC-25146
    Target: LRRK2
    Summary: LRRK2 inhibitor
      ≥24.45 mg/mL
  8. DCC-2036 (Rebastinib)
    B1404 DCC-2036 (Rebastinib)
    Target: FLT3|Bcr-Abl|Tie-2|KDR
    Summary: Bcr-Abl inhibitor
      ≥27.7 mg/mL
  9. Vandetanib (ZD6474)
    A8555 Vandetanib (ZD6474)
    Target: VEGFR|EGFR
    Summary: VEGFR2/EGFR antagonist
      insoluble in H2O; ≥11.88 mg/mL
  10. Axitinib (AG 013736)
    A8370 Axitinib (AG 013736)
     1 Citation
    Target: VEGFR|PDGFR|c-Kit
    Summary: VEGFR1/ c-Kit inhibitor
      insoluble in H2O; ≥19.3 mg/mL

Items 41-50 of 63

Page
per page
Shop By
Now Shopping by
  1. Category Tyrosine Kinase Remove This Item
  2. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Bcr-Abl 1 item
  2. Axl 2item
  3. ALK 3item
  4. c-FMS 1 item
  5. c-Kit 1 item
  6. c-MET 7item
  7. c-RET 2item
  8. CSF-1R 1 item
  9. EGFR 12item
  10. FAK 3item
  11. FGFR 4item
  12. HER2 5item
  13. LRRK2 4item
  14. PDGFR 6item
  15. Pyk2 2item
  16. Spleen Tyrosine Kinase (Syk) 3item
  17. Src 2item
  18. Tie-2 2item
  19. Trk 1 item
  20. VEGFR 19item
Specificity
  1. Selective 47item
Reversibility
  1. Reversible 6item
  2. Irreversible 4item
Target
  1. Raf 5item
  2. CSF-1R 1 item
  3. FLT3 4item
  4. Eph Receptors 1 item
  5. VEGFR 25item
  6. PDGFR 8item
  7. c-Kit 6item
  8. RET 2item
  9. Bcr-Abl 1 item
  10. FGFR 7item
  11. MET 4item
  12. Src 1 item
  13. Trk Receptors 2item
  14. EGFR 11item
  15. FAK 3item
  16. BMP and Other Activin Receptors 1 item
  17. Syk 3item
  18. ErbB 2item
  19. c-MET 3item
  20. Pyk2 3item
  21. LRRK2 4item
  22. Insulin and Insulin-like Receptors 1 item
  23. ALK 1 item
  24. Tie-2 3item
  25. Flk-1 1 item
  26. c-RET 1 item
  27. KDR 1 item
  28. Fyn kinase 1 item
  29. c-Fms tyrosine kinase 1 item
  30. Lyn kinase 1 item
  31. ErbB-2 1 item
  32. DCLK2 1 item
  33. Flk1 1 item
Related Disease
  1. Acute Myeloid Leukemia 2item
  2. Adrenocortical Carcinoma 1 item
  3. Advanced Renal Cell Carcinoma 1 item
  4. Bladder Cancer 4item
  5. Bladder Carcinoma 1 item
  6. Breast Cancer 13item
  7. Cancer 47item
  8. Cholangiocarcinoma 1 item
  9. Chronic Lymphocytic Leukemia 1 item
  10. Clear Cell Renal Cell Carcinoma 1 item
  11. Colon Cancer 3item
  12. Colon Carcinoma 1 item
  13. Colorectal Cancer 8item
  14. Glioblastoma 5item
  15. Glioma 2item
  16. Hepatocellular Carcinoma 2item
  17. Liver Cancer 2item
  18. Lung Cancer 4item
  19. Lung Carcinoma 1 item
  20. Lymphoma 1 item
  21. Melanoma 1 item
  22. Multiple Myeloma 3item
  23. Non-small Cell Lung Cancer 4item
  24. Ovarian Cancer 4item
  25. Pancreatic Cancer 8item
  26. Prostate Cancer 4item
  27. Renal Cancer 1 item
  28. Renal Cell Carcinoma 3item
  29. Rheumatoid Arthritis 1 item
  30. Thyroid Cancer 3item